Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest announcement is out from ImmuPharma ( (GB:IMM) ).
ImmuPharma PLC announced that its top executives will attend the Bio-Europe Conference in Vienna from November 3-5, 2025. This event, known as the premier biopharma partnering forum in Europe, will host over 5,700 life science professionals, fostering innovation and collaboration in the biotech sector, which could enhance ImmuPharma’s industry positioning and stakeholder engagement.
More about ImmuPharma
ImmuPharma PLC is a specialty biopharmaceutical company focused on discovering and developing peptide-based therapeutics. Its portfolio includes novel peptide therapeutics aimed at treating autoimmune diseases and anti-infectives.
Average Trading Volume: 11,732,053
Technical Sentiment Signal: Buy
Current Market Cap: £58.32M
Learn more about IMM stock on TipRanks’ Stock Analysis page.